Overview

Post-COVID-19 Chronic Fatigue Syndrome

Status:
Not yet recruiting
Trial end date:
2023-05-08
Target enrollment:
Participant gender:
Summary
Fatigue is recognized as one of the most commonly presented long-term complaints in individuals previously infected with SARS-CoV-2.
Phase:
Phase 4
Details
Lead Sponsor:
ClinAmygate
Collaborator:
As-Salam Center, Maadi, Cairo, Egypt
Treatments:
Thiamine